Hans Herfarth

9PUBLICATIONS
41CO-AUTHORS
Immunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)Child and adolescent developmentRespiratory diseasesAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 13, 2026
The Bidirectional Relationship Between Cognitive Function and Active Inflammatory Bowel Disease.

Bharati Kochar, Adam S Faye, Elizabeth Araka

|Jun 25, 2025
A Prospective Comparison of Ustekinumab and Antitumor Necrosis Factor α Therapy in the Treatment of Crohn's-Like Disease of the Pouch.

Edward L Barnes, Laura Raffals, Taha Qazi

|May 02, 2025
HLA DQA1*05 and Risk of Antitumor Necrosis Factor Treatment Failure and Anti-Drug Antibody Development in Children With Crohn's Disease.

Jeremy Adler, Joseph A Galanko, Rana Ammoury

|Oct 18, 2024
HLA DQA1*05 and risk of anti-TNF treatment failure and anti-drug antibody development in children with Crohn's Disease: HLA DQA1*05 and Pediatric Crohn's Disease.

Jeremy Adler, Joseph A Galanko, Rana Ammoury

|Apr 26, 2024
Efficacy and Safety of Liraglutide in Patients With an Ileal Pouch-Anal Anastomosis and Chronic High Bowel Frequency: A Placebo-Controlled, Crossover, Proof-of-Concept Study.

Hans Herfarth, Millie D Long, Jonathan J Hansen

|Mar 06, 2024
High Body Mass Index and Response to Anti-Tumor Necrosis Factor Therapy in Pediatric Crohn's Disease.

Dawn R Ebach, Traci W Jester, Joseph A Galanko

Pageof 2

Frequent Collaborators

4 joint publications

Michael D Kappelman

3 joint publications

Ajay S Gulati

3 joint publications

Tiffany M Linville

3 joint publications

Dawn R Ebach